Genzyme Bids For AnorMED Eyeing Stem Cell Transplantation Technology
Genzyme appeals directly to shareholders after rejection from AnorMed’s board of directors.
Genzyme appeals directly to shareholders after rejection from AnorMed’s board of directors.